agilon health (NYSE:AGL – Get Free Report) was downgraded by investment analysts at JMP Securities from an “outperform” rating to a “market perform” rating in a report issued on Monday, Marketbeat Ratings reports.
Several other equities analysts also recently issued reports on the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 price objective on shares of agilon health in a research report on Wednesday, August 7th. William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a report on Wednesday, October 2nd. Benchmark restated a “buy” rating and issued a $9.00 price objective on shares of agilon health in a research report on Thursday, August 8th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Three analysts have rated the stock with a sell rating, fifteen have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $7.03.
View Our Latest Stock Report on AGL
agilon health Stock Down 13.7 %
agilon health (NYSE:AGL – Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 46.06%. During the same quarter last year, the firm earned ($0.06) earnings per share. Equities research analysts predict that agilon health will post -0.32 earnings per share for the current fiscal year.
Insider Activity at agilon health
In related news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 3.20% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On agilon health
Several hedge funds have recently bought and sold shares of the company. J.Safra Asset Management Corp grew its holdings in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares during the period. City State Bank acquired a new stake in agilon health during the 3rd quarter worth $52,000. CWM LLC lifted its holdings in agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after acquiring an additional 7,288 shares in the last quarter. Nisa Investment Advisors LLC acquired a new position in agilon health in the second quarter valued at about $60,000. Finally, Bleakley Financial Group LLC bought a new stake in shares of agilon health in the first quarter worth about $65,000.
About agilon health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
- Five stocks we like better than agilon health
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Where to Find Earnings Call Transcripts
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Breakout Stocks: What They Are and How to Identify Them
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.